Recent Articles

• Novartis Completes HSR Waiting Period for Regulus Acquisition
• Idorsia's QUVIVIQ Gains Approval for China Market Expansion
• Significant Changes in EPH European Property Holdings' Ownership
• Sarclisa Gains Ground with Positive CHMP Opinion for Approval
• Promising Progress of Roche's NXT007 in Hemophilia A Treatment
• SBC Medical Strengthens Investor Relations Through Conferences
• Discover Summer Wonders in Morocco with Wego's New Campaign
• ICEYE's Strategic Partnership Boosts Netherlands Air Force ISR Tech
• APP Group Showcases Innovations for Sustainable Packaging Growth
• ICEYE Partners with Royal Netherlands Air Force for ISR Solutions
• HONGQI's Golden Sunflower Series Shines at Global Auto Expo
• Vooglam Elevates Festival Fashion with Interactive Eyewear
• Kinterra Capital Proposes to Acquire New World Resources Equity
• Blockchain Alliance International Champions Asia-Pacific Growth
• Risen Energy's Commitment to Sustainable Manufacturing and ESG
• Risen Energy's Commitment to Sustainability in ESG Practices
• Minjee Lee Shines at KPMG Women's PGA with Callaway Gear
• Promising Results of Equecabtagene Autoleucel in MS Therapy
• Explore ZA Miner's Exciting Offerings in Cloud Mining
• Global Collaboration to Revolutionize Treatment of Autoimmune Diseases
• Treeline Global Launches Revolutionary 25-Year Scientific Venture
• New Study Links Nightmares to Early Death and Aging Process
• Impact of Nightmares on Lifespan and Biological Aging Revealed
• Enhancing Heart Health: Oral Semaglutide for Diabetes Patients
• Molecular Partners Advances MP0726 with Orano Med Collaboration
• Mim8 Treatment for Haemophilia A: Promising Phase 3 Findings
• Mim8 Brings New Hope for Hemophilia A Patients: Study Insights
• Once-Weekly Insulin Efsitora Shows Promising Outcomes for Diabetes
• Innovative Inhaled Insulin Offers New Hope for Young Diabetics
• Lilly's Efsitora Alfa Offers Innovative Diabetes Treatment Solution
• Innovative Research Sheds Light on Uterine Cancer Treatment Paths
• Investigation of Luminar Technologies: What Investors Should Know
• Investigation Launched into Travere Therapeutics' Practices
• Meta Platforms Faces Investigation: Implications for Investors
• Investigation Launched into ADTRAN Holdings, Inc. (ADTN)
• Class Action Filed Against Red Cat Holdings, Inc. Over Securities
• Investigation on NeuroPace, Inc.: Protecting Investor Interests
• Investigation Launched into Groupon, Inc. - Discover the Details
• Understanding the Class Action Lawsuit Against Broadmark Realty Capital
• PTC Therapeutics Faces Scrutiny Amid Growing Investor Concerns
• Starbucks Faces Lawsuit Over Alleged Labor Code Violations
• Unleashing Daring Challenges: Explore Cajole's Unique Ventures
• Oklahoma City Mayor David Holt Leads New Era for Cities
• Opportunities for Investors in Rocket Pharmaceuticals Class Action
• FinThrive Unveils Agentic AI Technology for Revenue Cycle Success
• Monster Energy Athletes Shine at X Games Osaka, Making History
• Reckitt Benckiser Group Faces Class Action Lawsuit from Investors
• Investigation of Investor Claims Against Sanofi - SNY Alert
• Investigation Issued for NWTN Inc. Investors: Key Insights
• Apple Inc. Faces Class Action Over Siri Features Misleading Claims